API
< Back to all clusters
[HEALTH] · India · 2 sources

started · updated

India implements major price cuts for cancer medications

The Indian central government has launched a widespread pharmaceutical price reform, reducing the cost of numerous cancer medications by up to 96 percent. Led by the National Pharmaceutical Pricing Authority and the relevant ministry, the initiative aims to curb excessive profit margins and provide financial relief to families across the country.

The reform targets nearly 1,300 drug brands from approximately 85 pharmaceutical companies. Government estimates suggest the measure could result in annual savings of approximately 2.59 billion euros for patients. To assist with the transition, updated price lists are available via an official app, and official channels for reporting illegal pricing demands have been established.

While doctors and patient organizations have hailed the move as a significant milestone, consumer advocates have noted remaining gaps. Critics point out that some of the most expensive, exclusive therapies remain unaffected because the new price caps primarily regulate middleman margins rather than direct manufacturer prices.

Entities

National Pharmaceutical Pricing Authority